Lobbying and Political Spending

Report on Lobbying and Political Spending Activity: 

Board oversight of lobbying and political spending safeguards corporate reputations and protects shareholder value.  Compliant companies provide annual reporting on political contribution of all forms and account for all lobbying expenditures at both the State and Federal level as well as all payments to trade associations and 501(c)(4) social welfare nonprofits, which may be used to fund lobbying activities.  

For most companies in the opioid supply chain, the board risk report either included or referenced   board level oversight of both political spending and lobbying activities, as part of the topics to be covered in the board report to investors.  For companies which did not include these reports, resolutions may have been filed for enhanced transparency for either political spending or lobbying activities. 

With specific reference to opioids, shareholders also continue to urge the board to adopt a policy that the company will refrain from making dues, sponsorship or other payments to patient advocacy groups and medical professional organizations that engage in political activity that is not aligned with the company’s stated values and objectives regarding the opioid epidemic.  

 

IOPA Companies with Expanded Political Expenditure Disclosure

Company

Type

Vote 

Settlement Terms

Alkermes

Manufacturer

NA

Expanded Lobbying Disclosure

Endo

Manufacturer

NA

Expanded Lobbying Disclosure

Mallinckrodt

Manufacturer

NA

Expanded Political Disclosure

Mallinckrodt

Manufacturer

2019 - 80%

Expanded Lobbying Disclosure

McKesson

Distributor

2018 - 39%

Expanded Lobbying Disclosure

 

 

2019 - 46%

Expanded Lobbying Disclosure

 

 

2020 - 51%

Expanded Lobbying Disclosure

 

Sign Up for our eNewsletter

* indicates required